News

Aimmune Therapeutics to Present at the Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 16

BRISBANE, Calif.–(BUSINESS WIRE) — Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing CODIT™ (Characterized Oral Desensitization ImmunoTherapy) treatments for life-threatening food allergies, today announced that CEO Stephen Dilly, M.B.B.S., Ph.D., will present a company overview at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas on Tuesday, May 16, at 1:00 p.m. Pacific Time.

2017-06-27T11:56:33+00:00